Literature DB >> 34541175

An Optimized Method for the Production Using PEI, Titration and Neutralizationof SARS-CoV Spike Luciferase Pseudotypes.

George Carnell1, Keith Grehan1, Francesca Ferrara1, Eleonora Molesti1, Nigel Temperton1.   

Abstract

The protocol outlined represents a cost-effective, rapid and reliable method for the generation of high-titre viral pseudotype particles with the wild-type SARS-CoV spike protein on a lentiviral vector core using the widely available transfection reagent PEI. This protocol is optimized for transfection in 6-well plates; however it can be readily scaled to different production volumes according to application. This protocol has multiple benefits including the use of readily available reagents, consistent, high pseudotype virus production Relative Luminescence Units (RLU) titres and rapid generation of novel coronavirus pseudotypes for research into strain variation, tropism and immunogenicity/sero-prevalence.
Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Lentiviral pseudotype; SARS coronavirus; Virus neutralization

Year:  2017        PMID: 34541175      PMCID: PMC8413606          DOI: 10.21769/BioProtoc.2514

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  3 in total

Review 1.  Pseudotype-based neutralization assays for influenza: a systematic analysis.

Authors:  George William Carnell; Francesca Ferrara; Keith Grehan; Craig Peter Thompson; Nigel James Temperton
Journal:  Front Immunol       Date:  2015-04-29       Impact factor: 7.561

2.  Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes.

Authors:  Nigel J Temperton; Paul K Chan; Graham Simmons; Maria C Zambon; Richard S Tedder; Yasuhiro Takeuchi; Robin A Weiss
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

3.  An optimised method for the production of MERS-CoV spike expressing viral pseudotypes.

Authors:  K Grehan; F Ferrara; N Temperton
Journal:  MethodsX       Date:  2015-10-13
  3 in total
  1 in total

Review 1.  A How to Guide: Clinical Population Test Development and Authorization of MALDI-ToF Mass Spectrometry-Based Screening Tests for Viral Infections.

Authors:  Ray K Iles; Jason K Iles; Raminta Zmuidinaite; Michael Roberts
Journal:  Viruses       Date:  2022-09-03       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.